Predictors of Graft Function Improvement after Conversion from Calcineurin Inhibitors to Belatacept in Kidney Recipients with Calcineurin Inhibitor Nephrotoxicity.

被引:0
|
作者
Viglietti, D. [1 ]
Pievani, D. [1 ]
Louis, K. [1 ]
Glotz, D. [1 ]
Legendre, C. [1 ]
Loupy, A. [1 ]
Lefaucheur, C. [1 ]
机构
[1] Paris Translat Res Ctr Organ Transplantat, Paris, France
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
311
引用
收藏
页码:450 / 450
页数:1
相关论文
共 50 条
  • [1] PREDICTORS OF GRAFT FUNCTION IMPROVEMENT AFTER CONVERSION FROM CALCINEURIN INHIBITORS TO BELATACEPT IN KIDNEY RECIPIENTS WITH CALCINEURIN INHIBITOR NEPHROTOXICITY
    Pievani, Daniele
    Viglietti, Denis
    Louis, Kevin
    Glotz, Denis
    Legendre, Christophe
    Loupy, Alexandre
    Lefaucheur, Carmen
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 645 - 645
  • [2] Late Conversion from Calcineurin Inhibitors to Belatacept is Associated with a Sustained Improvement in Kidney Allograft Function.
    Sethi, S.
    Choi, J.
    Vo, A.
    Najjar, R.
    Peng, A.
    Jordan, S.
    Huang, E.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 791 - 791
  • [3] Conversion to Everolimus-Based Immunosuppression Regimen with Calcineurin Inhibitor Reduction Ameliorates Histological Damage in Kidney Transplant Recipients with Calcineurin Inhibitor-Induced Nephrotoxicity.
    Hotta, K.
    Iwahara, N.
    Tanabe, T.
    Shinohara, N.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 1083 - 1083
  • [4] Belatacept Conversion in Kidney Transplant: With or without Calcineurin Inhibitor Taper
    Elmasri, A.
    Valdepenas, B.
    Benken, S.
    Hajjiri, Z.
    Benken, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S845 - S846
  • [5] Belatacept in kidney transplant recipients switched from calcineurin inhibitors: results on renal function and safety after 6 months
    Bardo, P.
    Berdougo, B.
    Rouimi, E.
    Grimbert, P.
    Astier, A.
    Paul, M.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1301 - 1302
  • [6] Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients
    Tawhari, Ibrahim
    Hallak, Patrick
    Bin, Sofia
    Yamani, Fatmah
    Safar-Boueri, Maria
    Irshad, Aazib
    Leventhal, Joseph
    Ansari, Mohammed Javeed
    Cravedi, Paolo
    Gallon, Lorenzo
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [7] Belatacept Conversion for Calcineurin Inhibitor-Associated Thrombotic Microangiopathy in Kidney Transplant Recipients.
    Muhsin, S. A.
    Safa, K.
    Gilligan, H. M.
    Heher, E. C.
    Williams, W. W.
    Wojciechowski, D. M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 691 - 691
  • [8] Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial
    Bredewold, Obbo W.
    Chan, Joe
    Svensson, My
    Bruchfeld, Annette
    de Fijter, Johan W.
    Furuland, Hans
    Grinyo, Josep M.
    Hartmann, Anders
    Holdaas, Hallvard
    Hellberg, Olof
    Jardine, Alan
    Mjornstedt, Lars
    Skov, Karin
    Smerud, Knut T.
    Soveri, Inga
    Sorensen, Soren S.
    van Zonneveld, Anton-Jan
    Fellstrom, Bengt
    [J]. KIDNEY MEDICINE, 2023, 5 (01)
  • [9] Patterns of improvement in kidney function among patients converted to belatacept from calcineurin inhibitors for kidney allograft dysfunction
    Kumar, Dhiren
    Regmi, Anil
    Fattah, Hasan
    Dave, Hitarth
    Joseph, Justin
    Kimball, Pamela
    Sharma, Amit
    Bhati, Chandra S.
    Massey, Hugh D.
    King, Anne L.
    Gupta, Gaurav
    [J]. TRANSPLANTATION, 2016, 100 (07) : S83 - S83
  • [10] Conversion from Calcineurin Inhibitors to Belatacept in Kidney Recipients with Donor-Specific Anti-HLA Antibodies and Calcineurin Inhibitor Nephrotoxicity Decreases the Pathogenicity of Donor-Specific Anti-HLA Antibodies.
    Louis, K.
    Viglietti, D.
    Pievani, D.
    Aubert, O.
    Glotz, D.
    Legendre, C.
    Zeevi, A.
    Loupy, A.
    Lefaucheur, C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 449 - 450